Current Challenges and Emerging Approaches in IBD Management Evaluation (ID: i828a)

Question Title

* 1. Lucas is a 38-year-old man diagnosed with moderate-to-severe UC after being referred to a gastroenterologist for symptoms that began over a year ago. After having participated in this program, which of the following is most consistent with how you would approach minimizing his risk for irreversible bowel damage?

Initial 5-ASA and corticosteroid treatment, followed by advanced therapy in the event of poor response

Initial immunomodulator treatment, followed by advanced therapy in the event of poor response

Forego traditional treatment options in favor of earlier initiation of advanced therapy

Question Title

* 2. How many years have you been in practice?

≥21

11-20

1-10

Question Title

* 3. How many patients with IBD do you manage per month? 

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 4. Please select the option that best describes your practice setting. 

Academic medical center

Community medical center

VA, DOD, or other government

Managed care

Research

Pharmaceutical industry

Question Title

* 5. After participating in this activity, how confident are you in the management of patients with IBD in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 7. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 8. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Greater awareness of the high frequency of suboptimal outcomes in patients with UC

Increased skill in selecting therapeutic targets and monitoring disease activity in patients with UC

Increased understanding of the potential for improved health outcomes with earlier use of targeted therapies in patients with UC

Greater confidence in initiating treatment with targeted therapies for UC earlier in the disease course

Greater knowledge of clinical trial evidence regarding the efficacy and safety of newer and emerging UC therapies

Better able to make treatment decisions for treatment-naïve patients

Improved ability to differentiate the mechanisms of action and the efficacy and safety profiles of newer and emerging therapies for UC

Greater understanding of the need to directly identify patient goals and preferences related to the selection of UC treatment

Increased ability to incorporate patient preferences for the successful management of UC

Question Title

* 9. What barriers do you see to making changes in your practice? Please select all that apply. 

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement, or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.

After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Recognize the prevalence of suboptimal outcomes in IBD and understand the value of routine disease monitoring for successful management	Recognize the prevalence of suboptimal outcomes in IBD and understand the value of routine disease monitoring for successful management Strongly agree	Recognize the prevalence of suboptimal outcomes in IBD and understand the value of routine disease monitoring for successful management Agree	Recognize the prevalence of suboptimal outcomes in IBD and understand the value of routine disease monitoring for successful management Neutral	Recognize the prevalence of suboptimal outcomes in IBD and understand the value of routine disease monitoring for successful management Disagree	Recognize the prevalence of suboptimal outcomes in IBD and understand the value of routine disease monitoring for successful management Strongly disagree
Evaluate the benefits associated with the earlier introduction of new targeted therapies into the management of UC	Evaluate the benefits associated with the earlier introduction of new targeted therapies into the management of UC Strongly agree	Evaluate the benefits associated with the earlier introduction of new targeted therapies into the management of UC Agree	Evaluate the benefits associated with the earlier introduction of new targeted therapies into the management of UC Neutral	Evaluate the benefits associated with the earlier introduction of new targeted therapies into the management of UC Disagree	Evaluate the benefits associated with the earlier introduction of new targeted therapies into the management of UC Strongly disagree
Apply clinical data to clinical practice and incorporate new and emerging IBD therapies, once they become available, to improve patient outcomes	Apply clinical data to clinical practice and incorporate new and emerging IBD therapies, once they become available, to improve patient outcomes Strongly agree	Apply clinical data to clinical practice and incorporate new and emerging IBD therapies, once they become available, to improve patient outcomes Agree	Apply clinical data to clinical practice and incorporate new and emerging IBD therapies, once they become available, to improve patient outcomes Neutral	Apply clinical data to clinical practice and incorporate new and emerging IBD therapies, once they become available, to improve patient outcomes Disagree	Apply clinical data to clinical practice and incorporate new and emerging IBD therapies, once they become available, to improve patient outcomes Strongly disagree
Develop an evidence-based treatment selection protocol and incorporate patient preferences into shared decision-making for the successful management of IBD	Develop an evidence-based treatment selection protocol and incorporate patient preferences into shared decision-making for the successful management of IBD Strongly agree	Develop an evidence-based treatment selection protocol and incorporate patient preferences into shared decision-making for the successful management of IBD Agree	Develop an evidence-based treatment selection protocol and incorporate patient preferences into shared decision-making for the successful management of IBD Neutral	Develop an evidence-based treatment selection protocol and incorporate patient preferences into shared decision-making for the successful management of IBD Disagree	Develop an evidence-based treatment selection protocol and incorporate patient preferences into shared decision-making for the successful management of IBD Strongly disagree

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.

Marla C. Dubinsky, MD effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 12. Please rate your level of agreement by checking the appropriate rating.

Edward V. Loftus, Jr., MD effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the Material	Presented the Material Strongly agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly disagree

Question Title

* 13. Please rate your level of agreement by checking the appropriate rating.

The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Current Challenges and Emerging Approaches in IBD Management Evaluation (ID: i828a)

Question Title

Question Title

* 2. How many years have you been in practice?

Question Title

* 3. How many patients with IBD do you manage per month?

Question Title

* 4. Please select the option that best describes your practice setting.

Question Title

* 5. After participating in this activity, how confident are you in the management of patients with IBD in your practice?

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 7. Which of the following best describes the impact of this activity on your performance?

Question Title

* 8. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 9. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.

After participating in today’s activity, I am now better able to:

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.

Marla C. Dubinsky, MD effectively:

Question Title

* 12. Please rate your level of agreement by checking the appropriate rating.

Edward V. Loftus, Jr., MD effectively:

Question Title

* 13. Please rate your level of agreement by checking the appropriate rating.

The content presented:

Question Title

* 14. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 15. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 16. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for IBD:

Question Title

Question Title

* 2. How many years have you been in practice?

Question Title

* 3. How many patients with IBD do you manage per month?

Question Title

* 4. Please select the option that best describes your practice setting.

Question Title

* 5. After participating in this activity, how confident are you in the management of patients with IBD in your practice?

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 7. Which of the following best describes the impact of this activity on your performance?

Question Title

* 8. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 9. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating. After participating in today’s activity, I am now better able to:

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.Marla C. Dubinsky, MD effectively:

Question Title

* 12. Please rate your level of agreement by checking the appropriate rating.Edward V. Loftus, Jr., MD effectively:

Question Title

* 13. Please rate your level of agreement by checking the appropriate rating.The content presented:

Question Title

* 14. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 15. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 16. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for IBD:

* 3. How many patients with IBD do you manage per month? 

* 4. Please select the option that best describes your practice setting. 

* 9. What barriers do you see to making changes in your practice? Please select all that apply. 

* 10. Please rate your level of agreement by checking the appropriate rating.

After participating in today’s activity, I am now better able to:

* 11. Please rate your level of agreement by checking the appropriate rating.

Marla C. Dubinsky, MD effectively:

* 12. Please rate your level of agreement by checking the appropriate rating.

Edward V. Loftus, Jr., MD effectively:

* 13. Please rate your level of agreement by checking the appropriate rating.

The content presented: